Of the 50 different drugs approved by the U.S. Food and Drug Administration (FDA) in 2024, 18 of these agents were biosimilars, eight of which target reference products with no previous biosimilar ...

While biosimilar drugs promise greater affordability and accessibility for millions with chronic diseases, can this momentum of bringing biosimilars to the market persist despite the rising costs ...

Heroin remains the most seized drug. Areas under the Sector-39 police station have emerged as the hotbed of narcotics activity in Chandigarh, clocking the highest number of NDPS Act cases—85 ...

diabetes drugs hold top spot; biosimilar adoption up more than 27 per cent. "Private sector drug plans protect and increase access to pharmaceutical care, but they are in constant need of expert ...

Sandoz has signed a global collaboration agreement with Shanghai Henlius Biotech to commercialize a biosimilar of oncology therapy, ipilimumab (Bristol-Myers Squibb’s Yervoy). The agreement is ...

Biosimilars are near-identical copies of complex biologic drugs whose patents have expired. Saynor said some form of U.S. price reform is inevitable, pointing to President Donald Trump’s stalled ...

Biosimilars are near-identical copies of complex biologic drugs whose patents have expired. Saynor said some form of U.S. price reform is inevitable, pointing to President Donald Trump's stalled plan ...

Samsung Bioepis has released its Second Quarter 2025 Biosimilar Market Report, which provides the second quarter 2025 Average Sales Price and Wholesale Acquisition Cost of the commercially ...

Now, it is finally getting competition with the release of Amgen’s biosimilar drug, Amjevita. Humira’s main patent on Humira expired in 2016, but a byzantine patent saga has kept other drug ...

U.S. President Donald Trump signed an executive order favoring generic drugs to reduce the financial burden of healthcare on Americans. The core of the order is to simplify approval procedures and ...